Danske Bank A S Lowers Stock Position in Globe Life Inc. $GL

Key Points

• Danske Bank A/S cut its stake in Globe Life by 93.2% in Q4, selling 9,614 shares and finishing the quarter with 700 shares valued at about $98,000.
• Corporate insiders have been net sellers — CEO Frank M. Svoboda sold 12,500 shares (~$1.81M) and the CMO sold 10,000 shares, with insiders disposing of 121,470 shares (~$17.99M) in the past 90 days.
• Wall Street sentiment is generally positive with a consensus Buy rating and an average target of $172.67; GL trades near $154.49, reported Q1 EPS of $3.43 (slightly below estimates), and announced a $0.33 quarterly dividend (≈0.9% yield).

Danske Bank A S cut its stake in shares of Globe Life Inc. (NYSE:GL - Free Report) by 93.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 700 shares of the company's stock after selling 9,614 shares during the quarter. Danske Bank A S's holdings in Globe Life were worth $98,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Oakworth Capital Inc. raised its position in shares of Globe Life by 2.1% during the 4th quarter. Oakworth Capital Inc. now owns 29,153 shares of the company's stock valued at $4,077,000 after buying an additional 590 shares in the last quarter. Torren Management LLC bought a new stake in shares of Globe Life during the 4th quarter worth $37,000. Mitsubishi UFJ Trust & Banking Corp grew its position in Globe Life by 263.0% in the fourth quarter. Mitsubishi UFJ Trust & Banking Corp now owns 6,639 shares of the company's stock worth $929,000 after acquiring an additional 4,810 shares in the last quarter. M&T Bank Corp increased its stake in Globe Life by 45.5% in the fourth quarter. M&T Bank Corp now owns 15,523 shares of the company's stock valued at $2,171,000 after acquiring an additional 4,855 shares during the last quarter. Finally, Pictet Asset Management Holding SA increased its stake in Globe Life by 5.0% in the fourth quarter. Pictet Asset Management Holding SA now owns 15,372 shares of the company's stock valued at $2,150,000 after acquiring an additional 730 shares during the last quarter. Institutional investors own 81.61% of the company's stock.

Insider Activity

In related news, CEO Frank M. Svoboda sold 12,500 shares of the company's stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the completion of the sale, the chief executive officer directly owned 35,868 shares in the company, valued at $5,192,969.04. This represents a 25.84% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CMO Jennifer Allison Haworth sold 10,000 shares of the stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $143.14, for a total transaction of $1,431,400.00. Following the sale, the chief marketing officer directly owned 17,479 shares of the company's stock, valued at $2,501,944.06. The trade was a 36.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 121,470 shares of company stock valued at $17,988,368. Corporate insiders own 2.11% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on GL shares. Piper Sandler raised Globe Life to a "strong-buy" rating in a research note on Thursday, April 2nd. Weiss Ratings lowered Globe Life from a "buy (b)" rating to a "buy (b-)" rating in a research report on Monday, April 27th. Texas Capital raised Globe Life to a "strong-buy" rating in a report on Wednesday, March 18th. Wells Fargo & Company boosted their target price on Globe Life from $171.00 to $172.00 and gave the stock an "overweight" rating in a research report on Friday, April 10th. Finally, Keefe, Bruyette & Woods reiterated a "moderate buy" rating and set a $168.00 price target on shares of Globe Life in a research report on Thursday, March 26th. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average target price of $172.67.

Globe Life Stock Up 0.2%

Shares of NYSE:GL opened at $154.49 on Thursday. The stock has a market capitalization of $12.12 billion, a P/E ratio of 10.68 and a beta of 0.50. The stock's 50-day moving average price is $144.75 and its 200-day moving average price is $140.27. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.39. Globe Life Inc. has a 12-month low of $116.73 and a 12-month high of $156.69.

Globe Life (NYSE:GL - Get Free Report) last released its earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing analysts' consensus estimates of $3.46 by ($0.03). The company had revenue of $1.56 billion during the quarter, compared to the consensus estimate of $1.56 billion. Globe Life had a net margin of 19.38% and a return on equity of 21.30%. The company's revenue was up 5.3% on a year-over-year basis. During the same period last year, the firm posted $3.07 EPS. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. On average, equities analysts anticipate that Globe Life Inc. will post 15.53 earnings per share for the current year.

Globe Life Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be given a $0.33 dividend. The ex-dividend date is Monday, July 6th. This represents a $1.32 annualized dividend and a yield of 0.9%. Globe Life's payout ratio is presently 9.13%.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.